$14.41
+1.14 (+8.59%)
Performance
1D
+0.00%
1W
+2.56%
1M
-6.79%
3M
-20.47%
6M
+38.03%
1Y
+534.80%
YTD
+301.39%
Open$13.42
Previous Close$13.27
Day High$14.43
Day Low$13.11
52W High$24.28
52W Low$2.11
Volume—
Avg Volume4.37M
Market Cap5.04B
P/E Ratio—
EPS$-0.95
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$15.08
Below
SMA 200
$15.11
Below
RSI (14)
55.2
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+71.1% upside
Current
$14.41
$14.41
Target
$24.65
$24.65
$19.75
$24.65 avg
$31.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.62M | 918.48M | 827.43M |
| Net Income | -100,463,137 | -95,918,574 | -115,001,691 |
| Profit Margin | -11.2% | -10.4% | -13.9% |
| EBITDA | -104,291,949 | -115,509,109 | -110,721,792 |
| Free Cash Flow | -130,963,293 | -137,514,931 | -125,568,165 |
| Rev Growth | +16.3% | +1.8% | +8.3% |
| Debt/Equity | 0.25 | 0.25 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |